 WOBURN, Mass., Jan. 28, 2021 GLOBE NEWSWIRE -- NeuroMetrix, Inc. Nasdaq: NURO today reported financial and business highlights for the quarter and year ended December 31, 2020. The Company is focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of disorders involving the nervous system. 